National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Search
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Breast Cancer Screening (PDQ®)
Patient VersionHealth Professional VersionLast Modified: 05/08/2008



Purpose of This PDQ Summary






Summary of Evidence






Significance






Breast Cancer Diagnosis






Breast Cancer Screening Modalities






Effect of Screening on Breast Cancer Mortality






Harms of Screening






Special Populations






Get More Information From NCI







Changes to This Summary (05/08/2008)






Questions or Comments About This Summary






More Information



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

NIH Calendar of Events

Español
NCI Highlights
New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

President's Cancer Panel Annual Report: 2006-2007

Cancer Trends Progress Report: 2007 Update

Past Highlights
HPV Vaccines for Cervical Cancer
Changes to This Summary (05/08/2008)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Breast Cancer Diagnosis

Updated ductal carcinoma in situ incidence estimate for 2008.

Breast Cancer Screening Modalities

Added text to state that most screening mammography in the United States uses screen-film technology.

Added text to state that a large cohort of women was evaluated at 33 U.S. centers in the Digital Mammographic Imaging Screening Trial, showing no differences in mammographic sensitivity and specificity.

Added text about an Italian trial of parallel cohorts of 14,385 women matched for age and interpreting radiologist were screened by either full-field digital or screen-film mammography (cited Del Turco et al. as reference 45).

Added text to state that the Oslo II Study randomly assigned women to screening by digital mammography (n = 6,944) versus screen-film mammography (n = 16,985) with soft-copy double reading by experienced radiologists (cited Skaane et al. as reference 46).

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov